Medicine and Dentistry
Tuberculosis Treatment
100%
Rifapentine
100%
Drug Megadose
100%
Human Immunodeficiency Virus
80%
Puerperium
60%
Clinical Trial
60%
Prevalence
40%
Pharmacokinetics
20%
Adverse Outcome
20%
Drug Resistant Tuberculosis
20%
Adolescence
20%
Spontaneous Abortion
20%
Premature Labor
20%
Pharmacology, Toxicology and Pharmaceutical Science
Rifapentine
100%
HIV
100%
Clinical Trial
75%
Prevalence
50%
Premature Labor
25%
Pharmacokinetics
25%
Spontaneous Abortion
25%
Drug Resistant Tuberculosis
25%
Adverse Outcome
25%
Biochemistry, Genetics and Molecular Biology
Drug Megadose
100%
Human Immunodeficiency Virus
100%
Puerperium
75%
Clinical Trial
75%
Prevalence
50%
Pharmacokinetics
25%
Adolescence
25%